Does LETROZOLE Cause Second primary malignancy? 266 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 266 reports of Second primary malignancy have been filed in association with LETROZOLE (Letrozole). This represents 0.9% of all adverse event reports for LETROZOLE.
266
Reports of Second primary malignancy with LETROZOLE
0.9%
of all LETROZOLE reports
27
Deaths
71
Hospitalizations
How Dangerous Is Second primary malignancy From LETROZOLE?
Of the 266 reports, 27 (10.2%) resulted in death, 71 (26.7%) required hospitalization, and 15 (5.6%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
Yes, Second primary malignancy is listed as a known adverse reaction in the official FDA drug label for LETROZOLE.
What Other Side Effects Does LETROZOLE Cause?
Neutropenia (3,683)
Fatigue (3,568)
Malignant neoplasm progression (3,445)
Nausea (2,894)
Arthralgia (2,318)
Diarrhoea (2,282)
Metastases to bone (1,735)
Dyspnoea (1,621)
Asthenia (1,589)
Vomiting (1,560)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which LETROZOLE Alternatives Have Lower Second primary malignancy Risk?
LETROZOLE vs LETROZOLE\RIBOCICLIB
LETROZOLE vs LEUCOVORIN
LETROZOLE vs LEUCOVORIN\LEUCOVORIN
LETROZOLE vs LEUPROLIDE
LETROZOLE vs LEVALBUTEROL